Ravi Venkataramanan – Navin Fluorine International Ltd.
View Detailed Executive Profile →Professional Overview
- Ravi Venkataramanan co-founded Samnan Chemicals Pvt Ltd, starting in October 2023, marking a significant new venture in the chemical industry.
- Prior to this, Ravi served as the Chief Executive Officer of Navin Fluorine International Ltd. from February 2022 until October 2023, leading strategic initiatives that expanded the company’s market presence.
- During the tenure at Navin Fluorine International Ltd., Ravi played a pivotal role in enhancing operational efficiencies and driving innovative chemical solutions tailored to diverse industrial needs.
- Ravi's leadership at Aurigene Pharmaceutical Services Limited as CEO from June 2020 to February 2022 was marked by improvements in service offerings and client engagement in the pharmaceutical sector.
- In a previous role as the Global Business Head of Custom Pharmaceutical Services at Dr. Reddy’s Laboratories from December 2018 to June 2020, Ravi was instrumental in expanding the global reach of personalized pharmaceutical services.
- Ravi held multiple senior positions at Sai Life Sciences Ltd, including Senior Vice President of Global Business Development & Program Management from April 2018 to December 2018 and Vice President & Head of Products - API & Formulations from October 2013 to December 2018, focusing on strategic product development and market penetration.
- In these roles, Ravi faced numerous challenges, including navigating competitive market landscapes and evolving regulatory frameworks while ensuring robust growth and profitability for the organizations.
- Ravi's extensive experience across various leadership positions reflects a strong commitment to advancing innovation within the chemical and pharmaceutical industries.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Sai Life Sciences Ltd | Vice President & Head - Products - API & Formulations | Oct 2013 – Dec 2018 |
| Aurigene Pharmaceutical Services Limited | CEO | Jun 2020 – Feb 2022 |
| Navin Fluorine International Ltd. | Chief Executive Officer | Feb 2022 – Oct 2023 |
| Dr. Reddy’s Laboratories | Global Business Head of Custom Pharmaceutical Services | Dec 2018 – Jun 2020 |
| Sai Life Sciences Ltd | Senior Vice President | Dec 2014 – Mar 2018 |
| Sai Life Sciences Ltd | Senior Vice President - Global Business Development & Program Management | Apr 2018 – Dec 2018 |
| Samnan Chemicals Pvt Ltd | Co-Founder | Oct 2023 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Navin Fluorine International Ltd. corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Ravi Venkataramanan's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Navin Fluorine International Ltd.'s official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)